https://doi.org/10.3389/fonc.2021.649682
C
Chengguang Hu
Nanfang Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
224
Citations
10
h-index
10
i10-index
Chengguang Hu is an academic researcher from Nanfang Hospital. The author has contributed to research in topics: Hepatitis C virus research & Hepatitis B Virus Studies & Liver Disease Diagnosis and Treatment. The author has an h-index of 10, co-authored 25 publications.
ORCID: 0000-0002-1484-6854Papers by this author
worksPreoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy
2021 · Frontiers in Oncology · 14 citations
A Novel Post-Operative ALRI Model Accurately Predicts Clinical Outcomes of Resected Hepatocellular Carcinoma Patients
2021 · Frontiers in Oncology · 9 citations
https://doi.org/10.3389/fonc.2021.665497
PPP2R5D promotes hepatitis C virus infection by binding to viral NS5B and enhancing viral RNA replication
2022 · Virology Journal · 5 citations
https://doi.org/10.1186/s12985-022-01848-5
A different inhibitor is required for overcoming entecavir resistance: a comparison of four rescue therapies in a retrospective study
2017 · British Journal of Clinical Pharmacology · 4 citations
https://doi.org/10.1111/bcp.13330
A hiddenly high hepatitis C virus related liver disease burden among Chinese patients with non-liver disease complaints: A hospital based study from 2013 to 2017
2018 · Asian Pacific Journal of Tropical Medicine · 1 citations
https://doi.org/10.4103/1995-7645.225028
Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.11902212
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat